Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes

ClinicalTrials.gov ID: NCT07357740

Public ClinicalTrials.gov record NCT07357740. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 2:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study to Compare Two Presentations of CagriSema in Participants With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being done to look at how well a study medicine called CagriSema helps people with diabetes lower their blood sugar. In this study the sponsor will compare two version of CagriSema injected by two different types of injection devices. Which treatment participants get is decided by chance. CagriSema is still being tested in studies and is not yet available for doctors to prescribe. The study will last for about 38 weeks.

Study identification

NCT ID
NCT07357740
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 27, 2026 (Estimated)
Primary completion
Aug 25, 2027 (Estimated)
Completion
Oct 13, 2027 (Estimated)
Last update posted
Jul 9, 2026

2026 – 2027

United States locations

U.S. sites
21
U.S. states
10
U.S. cities
19
Facility City State ZIP Site status
Arkansas Clinical Research Little Rock Arkansas 72205 —
Paradigm Clinical Research San Diego California 92108 —
Encompass Clinical Research_Spring Valley Spring Valley California 91978 —
Diablo Clinical Research, Inc. Walnut Creek California 94598 —
Future Medical Research Longwood Florida 32750 —
New Horizon Research Center Miami Florida 33165 —
Clinical Site Partners Kendall Flourish Research Miami Florida 33186 —
West Orange Endocrinology Ocoee Florida 34761 —
Center for Diab,Obes & Metab Pembroke Pines Florida 33024 —
American Research Centers of Florida Pembroke Pines Florida 33027 —
Hope Clin Res & Wellness Conyers Georgia 30094 —
Elevate Clinical Research Gurnee Illinois 60031 —
Accellacare of Duly Oak Lawn Oak Lawn Illinois 60453 —
KDCILM, LLC & Accellacare US, Inc. Wilmington North Carolina 28401 —
Advanced Medical Research - Maumee Maumee Ohio 43537 —
Clinical Res Collaborative Cumberland Rhode Island 02864 —
Clinical Research Associates Nashville Tennessee 37203 —
The Endocrine Center Houston Texas 77079 —
Radiance Clinical Research Lampasas Texas 76550 —
Quality Research Inc San Antonio Texas 78209 —
Medrasa Clinical Research Sherman Texas 75092 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07357740, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 9, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07357740 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →